Medical device recalls Moderate risk

Beckman Coulter, Inc. recalls Access Thyroglobulin Antibody II, REF A32898, containing Instructions for Use, IFU REF B14994, B63978, and A38168. The…

Recall date
September 5, 2024
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0265-2025
FDA classification
Class II
Brand / firm
Beckman Coulter, Inc.
Sold / distributed
Distribution was made nationwide to the U.S., including Puerto Rico. There was government distribution but no military distribution. Foreign distribution was made to Mexico.

Why it was recalled

IFUs for the device incorrectly states the biotin interference was remediated. The issue could result in potentially false-low results.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Access Thyroglobulin Antibody II, REF A32898, containing Instructions for Use, IFU REF B14994, B63978, and A38168. The Access Thyroglobulin Antibody II (TgAb) assay is used for the quantitative determination of thyroglobulin antibody levels in human serum and plasma using the Access Immunoassay Systems.

Get recall alerts

Free email alert whenever Beckman Coulter, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Beckman Coulter, Inc.